A Single-dose, Open-label, Randomised, Crossover Bioequivalence Study in Healthy Young Men Comparing Two Formulations of Escitalopram.

Trial Profile

A Single-dose, Open-label, Randomised, Crossover Bioequivalence Study in Healthy Young Men Comparing Two Formulations of Escitalopram.

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Dec 2012

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Depressive disorders; Generalised anxiety disorder; Obsessive-compulsive disorders; Panic disorder; Social phobia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Nov 2011 Results reported at the 11th International Forum on Mood and Anxiety Disorders.
    • 18 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top